The evidence that ILD was internalised by the target cells might serve as one avenue for enabling immunoliposomes to overcome the drug resistance, as demonstrated by Suzuki et al (1997) that an immunoliposome targeting transferrin receptor (internalising receptor) modulates DXR resistance in DXR-resistant human leukaemia cells. Here, TFRC is linked to leukemia.